Search

everythinglearnresearchcommunity

for

Search:↓

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Adenosine helps hair grow longer and stronger by boosting certain growth factors and signaling pathways.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Miliacin with polar lipids helps hair growth and improves hair loss in women.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Trichobiolight effectively treats hair loss with 82.5% success.

Wiesbaden 30C effectively reduces hair fall and improves hair growth in young adults with Telogen Effluvium.

Licorice extract helps hair growth and may treat hair loss.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Increasing Wnt5a in mice skin delays hair growth but doesn't stop it.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.